SE7703930L - Vattenlosning och forfarande for framstellning derav - Google Patents

Vattenlosning och forfarande for framstellning derav

Info

Publication number
SE7703930L
SE7703930L SE7703930A SE7703930A SE7703930L SE 7703930 L SE7703930 L SE 7703930L SE 7703930 A SE7703930 A SE 7703930A SE 7703930 A SE7703930 A SE 7703930A SE 7703930 L SE7703930 L SE 7703930L
Authority
SE
Sweden
Prior art keywords
procedure
manufacture
water disposal
disposal
water
Prior art date
Application number
SE7703930A
Other languages
English (en)
Swedish (sv)
Inventor
H Kleui
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7703930L publication Critical patent/SE7703930L/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Inspection Of Paper Currency And Valuable Securities (AREA)
SE7703930A 1976-04-05 1977-04-04 Vattenlosning och forfarande for framstellning derav SE7703930L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT243476A AT345607B (de) 1976-04-05 1976-04-05 Verfahren zur herstellung einer stabilen waesserigen ipronidazol-loesung

Publications (1)

Publication Number Publication Date
SE7703930L true SE7703930L (sv) 1977-10-06

Family

ID=3534277

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703930A SE7703930L (sv) 1976-04-05 1977-04-04 Vattenlosning och forfarande for framstellning derav

Country Status (12)

Country Link
US (1) US4089968A (it)
AR (1) AR211953A1 (it)
AT (1) AT345607B (it)
AU (1) AU510536B2 (it)
CA (1) CA1080621A (it)
FR (1) FR2347354A1 (it)
GB (1) GB1563656A (it)
IT (1) IT1143636B (it)
NO (1) NO771195L (it)
NZ (1) NZ183754A (it)
SE (1) SE7703930L (it)
ZA (1) ZA771895B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230887C2 (de) * 1981-08-21 1995-02-02 May & Baker Ltd Verwendung von Nitroimidazol-Verbindungen zur Bekämpfung obligat anaerober, sulfatreduzierender Bakterien in technischen Flüssigkeiten
BR9405079A (pt) * 1994-01-10 1995-09-26 Santiago Abelardo Bojali Jaber Produto químico antiamebiano e antiprotozário e processo para sua obtenção

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634446A (en) * 1969-10-06 1972-01-11 Hoffmann La Roche 1-methyl-2-isopropyl-5-nitroimidazole and water soluble salts thereof

Also Published As

Publication number Publication date
NZ183754A (en) 1980-03-05
ZA771895B (en) 1978-03-29
IT1143636B (it) 1986-10-22
GB1563656A (en) 1980-03-26
AR211953A1 (es) 1978-04-14
AT345607B (de) 1978-09-25
FR2347354B1 (it) 1981-11-27
ATA243476A (de) 1977-12-15
FR2347354A1 (fr) 1977-11-04
US4089968A (en) 1978-05-16
AU2389377A (en) 1978-10-05
AU510536B2 (en) 1980-07-03
NO771195L (no) 1977-10-06
CA1080621A (en) 1980-07-01

Similar Documents

Publication Publication Date Title
SE7904690L (sv) Cyanokarboxamidiner och kinazolin-forfarande
FI773061A (fi) Adsorbentfraktioneringskolonn och foerfarande med funktionssaeker cykelkontroll
FI772778A (fi) Portabla och foeraenderliga vaeggsystem
FI773870A (fi) Handskfoerpackning och aemne foer densamma
FI770510A (fi) Anordning foer loesgoerande och avlaegsnande av en pipetts engaongsspets
FI773558A (fi) Skeppsbottenfaerg och liknande
FI790918A (fi) Vaermepump med flera kompressorer och med koordinerad avfrostning
SE430517B (sv) Elektrolysforfarande och elektrolysror
FI773031A (fi) Haollbara aeggprodukter och foerfarande foer deras framstaellning
FI773519A (fi) Flotationsfoerfarande och uppsamlingskomposition
FI791229A (fi) Infaestningselement med foerankringsbult och exepansionskil
FI773784A (fi) Framstaellning av vissa immuna nukleinsyror celldialysat och antikroppar
SE7902397L (sv) Lascylinder och nyckel
AT372251B (de) Wegwerfwindel
FI773801A (fi) Hydroxamsyror och foerfarande foer deras framstaellning
FI773768A (fi) Luggtextilfoeremaol och foerfarande foer deras framstaellning
AT361883B (de) Wegwerfwindel
SE7606427L (sv) Ampull och ampullberare
FI773954A (fi) Steroliner och deras anvaendning
SE7714222L (sv) Forfarande och kopplingsmedel
FI772453A (fi) Dihydro-oxo-nikotinsyror och foerfarande foer deras framstaellning
SE7713678L (sv) Forfarande och anordning for klarning av avloppsvatten
FI773822A (fi) Antitumoerglykosider och foerfarande foer framstaellning daerav
SE7705873L (sv) Bensensulfonykarbamider och forfarande for deras framstellning
FI791127A (fi) Elektronkanon med hoeg spaenning och liten foerstoringsfaktor